BNP Paribas Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.76M Sell
418,149
-1,481,512
-78% -$33.4M 0.01% 719
2025
Q4
$43.7M Buy
1,899,661
+354,382
+23% +$11.7M 0.05% 336
2025
Q3
$46.5M Buy
1,545,279
+93,149
+6% +$2.79M 0.12% 183
2025
Q2
$52.8M Buy
1,452,130
+301,674
+26% +$10.9M 0.13% 163
2025
Q1
$41.7M Buy
1,150,456
+192,379
+20% +$8M 0.11% 196
2024
Q4
$40.3M Buy
958,077
+233,895
+32% +$11.6M 0.1% 214
2024
Q3
$40.2M Sell
724,182
-106,193
-13% -$5.41M 0.1% 209
2024
Q2
$34.1M Buy
830,375
+323,280
+64% +$13.8M 0.09% 232
2024
Q1
$23.7M Buy
507,095
+424,476
+514% +$20M 0.06% 281
2023
Q4
$3.95M Buy
+82,619
New +$3.2M 0.01% 567
2022
Q3
Sell
-8,139
Closed -$486K 959
2022
Q2
$486K Buy
+8,139
New +$501K ﹤0.01% 849

Other funds holding RARE